Rockwell Medical, Inc. (RMTI)

Rockwell Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	10.52	10.71	15.66	8.98	10.1	13.28
Short-Term Investments	14.28	14.29	5.94	1.95	11.39	9.16
Cash & Short-Term Investments	24.8	25	21.6	10.94	21.49	22.44
Cash Growth	34.61%	15.72%	97.55%	-49.12%	-4.22%	-61.76%
Accounts Receivable	8.31	8.14	8.29	10.9	6.26	5.91
Receivables	8.31	8.14	8.29	10.9	6.26	5.91
Inventory	2.82	3.42	5.78	5.87	5.81	4.08
Prepaid Expenses	0.44	1.6	1.36	1.06	1.75	2.86
Total Current Assets	36.36	38.16	37.03	28.77	35.31	35.29
Property, Plant & Equipment	9.31	7.85	10.34	11.02	8.61	10.22
Goodwill	0.92	0.92	0.92	0.92	0.92	0.92
Other Intangible Assets	9.38	9.66	10.21	10.76	-	-
Other Long-Term Assets	0.56	0.56	0.71	0.71	1.8	2.14
Total Assets	56.53	57.15	59.21	52.17	46.64	48.57

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.18	2	2.87	4.52	4.05	3.74
Accrued Expenses	2.54	3.52	4.86	5.49	7.12	4.29
Short-Term Debt	-	0.26	0.27	0.24	0.5	0.44
Current Portion of Long-Term Debt	1.77	-	-	-	1.63	7.38
Current Portion of Leases	1.9	1.62	2.17	1.94	2.01	2
Current Unearned Revenue	0.36	1.36	2.51	2.79	1.8	2.32
Other Current Liabilities	1.43	0.81	1.42	1.66	0.59	0.8
Total Current Liabilities	11.17	9.58	14.09	16.64	17.69	20.97
Long-Term Debt	7.24	8.83	8.47	8.29	7.56	13.19
Long-Term Leases	3.03	1.76	2.63	2.96	4.67	5.89
Long-Term Unearned Revenue	-	-	1.43	2.98	2.6	5.99
Other Long-Term Liabilities	-	-	-	0.01	0.01	0.01
Total Liabilities	21.44	20.16	26.62	30.88	32.53	46.04

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	-	0	0	0	0	0
Additional Paid-In Capital	440.72	439.84	430.21	418.49	402.7	372.56
Retained Earnings	-405.77	-402.99	-397.68	-397.2	-388.76	-370.08
Comprehensive Income & Other	0.13	0.13	0.05	-0	0.16	0.05
Shareholders' Equity	35.09	36.98	32.59	21.29	14.11	2.54
Total Liabilities & Equity	56.53	57.15	59.21	52.17	46.64	48.57

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	13.93	12.47	13.54	13.44	16.36	28.9
Net Cash (Debt)	10.86	12.53	8.07	-2.5	5.13	-6.46
Net Cash Growth	146.07%	55.26%	-	-	-	-
Net Cash Per Share	2.81	3.48	2.60	-1.07	3.59	-7.57
Filing Date Shares Outstanding	4.03	3.94	3.41	2.93	1.26	0.85
Total Common Shares Outstanding	3.97	3.94	3.41	2.91	1.22	0.85
Working Capital	25.19	28.58	22.94	12.13	17.62	14.32
Book Value Per Share	8.83	9.38	9.57	7.31	11.60	2.97
Tangible Book Value	24.79	26.4	21.46	9.61	13.19	1.61
Tangible Book Value Per Share	6.24	6.70	6.30	3.30	10.84	1.89
Machinery	12.29	13.78	14.63	13.78	8.57	8.39
Leasehold Improvements	1.22	1.57	1.56	1.42	1.26	1.2

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error